Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

PhotoMedex Seeks FDA OK of Laser for Atopic Dermatitis
May 2001
RADNOR, Pa., May 18 -- PhotoMedex Inc. has submitted an application for 510 (k) clearance from the US Food and Drug Administration to commercially market its XTRAC laser system for the treatment of Atopic Dermatitis. Atopic Dermatitis, commonly known as eczema, is a chronic inflammation of the skin that can afflict persons of any age, but is considered to be the most common skin condition in children under the age of 11.

lasersNews & Features

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.